symmetric dimethylarginine has been researched along with leptin in 2 studies
| Studies (symmetric dimethylarginine) | Trials (symmetric dimethylarginine) | Recent Studies (post-2010) (symmetric dimethylarginine) | Studies (leptin) | Trials (leptin) | Recent Studies (post-2010) (leptin) |
|---|---|---|---|---|---|
| 428 | 27 | 314 | 25,940 | 1,628 | 11,468 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, K; Nishio, I; Tsuda, K | 1 |
| Atzler, D; Ayers, CR; de Lemos, JA; Gore, MO; Hackler, E; Khera, A; Lew, J; Lewis, A; Neeland, I; Omland, T; Rohatgi, A | 1 |
2 other study(ies) available for symmetric dimethylarginine and leptin
| Article | Year |
|---|---|
Leptin improves membrane fluidity of erythrocytes in humans via a nitric oxide-dependent mechanism--an electron paramagnetic resonance investigation.
Topics: Arginine; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; Erythrocyte Membrane; Humans; In Vitro Techniques; Kinetics; Leptin; Membrane Fluidity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Reference Values | 2002 |
Racial Differences in Cardiovascular Biomarkers in the General Population.
Topics: Adiponectin; Adult; Albuminuria; Antibodies, Antinuclear; Arginine; Biomarkers; Black or African American; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrin Fibrinogen Degradation Products; Homoarginine; Humans; Interleukin-1 Receptor-Like 1 Protein; Leptin; Linear Models; Lipoprotein(a); Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Osteoprotegerin; Peptide Fragments; Proportional Hazards Models; Receptor for Advanced Glycation End Products; Troponin T; White People | 2019 |